Wu-5

N/A

Report date: 2022/01/11 18:01:14
NME

Base Information

Drug NameWu-5
Drug Alias NameWu-5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin Specific Peptidase 10 inhibitors
TargetsUbiquitin Specific Peptidase 10
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Jiaotong University
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Jiaotong University
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A